Jurnista (Hydromorphone Hydrochloride Tablet) 32mg

Jurnista (hydromorphone hydrochloride) 32mg tablets are a strong opioid pain relief medication. This extended-release form provides long-lasting comfort for moderate to severe pain. Store at room temperature and keep out of reach of children. Always follow healthcare provider instructions.

Strength

32mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

Janssen - Cilag AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Hydromorphone hydrochloride 32mg tablets are prescribed to manage moderate to severe pain that requires around-the-clock opioid treatment. This extended-release formulation is designed for patients already using opioid pain relievers who need continuous relief. It is not intended for as-needed pain control or for mild pain. what is hydromorphone used for

Side Effects

This medication works by changing how the brain and nervous system respond to pain signals. Patients may experience steady pain relief over 24 hours with this extended-release tablet. Common effects include drowsiness, constipation, or mild nausea, especially when starting treatment. Effects vary by individual and may take time to stabilize.

Precautions & Warnings

Keep this medication in its original packaging and store at room temperature away from moisture and heat. Always keep it in a secure location to prevent accidental ingestion by others, especially children or pets. Do not crush, chew, or split the tablets unless directed by a healthcare professional. Dispose of unused medication properly through take-back programs.

Avoid Interactions

Hydromorphone can interact with other substances that slow breathing or cause drowsiness, such as alcohol, benzodiazepines, or sleep medications. Certain antidepressants, antifungal drugs, or antibiotics may affect how this medication works. Always inform your healthcare provider about all medications and supplements you are taking before starting hydromorphone.

Frequently Asked Questions

No, Jurnista 32mg is designed for moderate to severe pain that requires continuous opioid treatment.

Jurnista is an extended-release tablet designed to provide pain relief for up to 24 hours.

This medication should only be used during pregnancy if clearly needed and under medical supervision.

Alcohol can increase the risk of serious side effects and should be avoided while taking Jurnista.

Take the missed dose as soon as you remember unless it is almost time for your next dose; skip the missed dose and resume your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.